AI Science Tracker
EN

Evaluating AI-Based Mitosis Detection for Breast Carcinoma in Digital Pathology: A Clinical Study on Routine Practice Integration.

Primaa, 75002 Paris, France; Hôpital Bicêtre (AP-HP), Paris-Saclay University, 94270 Kremin-Bicêtre, France; Gustave-Roussy Cancer Campus—Grand Paris, 94800 Villejuif, France; Hôpital Saint-Louis (AP-HP), Paris Cité University, 75010 Paris, France; Institut Curie, PSL University, 75005 Paris, France · 28 Apr 2025 · medicine

Discovery

Evaluating AI-Based Mitosis Detection for Breast Carcinoma in Digital Pathology: A Clinical Study on Routine Practice Integration.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: With AI assistance, two pathologists improved mitotic scoring accuracy against expert consensus on routine-practice breast-cancer whole-slide images (62%/64% to 76%/78%) and improved interobserver agreement; the evaluation was limited to one hospital and a 50-case reading study.

Technology: An AI mitosis-detection/hotspot workflow assists pathologists reading whole-slide images and contributes mitotic evidence to routine scoring.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An AI mitosis-detection/hotspot workflow assists pathologists reading whole-slide images and contributes mitotic evidence to routine scoring.
Limitation / still unknown
The reading study involved 50 cases at one hospital; performance and reader agreement beyond that study were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12071563/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.